Item 9 Labs Stock Price, News & Analysis

INLB OTC

Company Description

Item 9 Labs Corp. is a United States-based company specializing in the production of cannabis and cannabis-related products. They offer a wide range of products including flower, concentrates, distillates, and hardware. The company distributes medical cannabis strains, shatter, crumble, badder, thca, delta 8 thc, broad spectrum distillate, and live resin terpene sauce through licensed dispensaries in Arizona. Their headquarters are located in Phoenix, Arizona.

Item 9 Labs Corp. has retained Sharp Capital Advisors LLC to explore a potential sale of the Company. With two core operating businesses, Item 9 Labs and Unity Rd., the company has made significant strides in the cannabis industry. Item 9 Labs operates a highly efficient cultivation facility, while Unity Rd. is the first national cannabis dispensary franchisor. The Company also owns an additional asset in Pahrump, Nevada.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

- %

Performance 1 year

$10.2K

Market Cap

102.4M

Shares outstanding

Latest News

View All

December 19, 2023

8.70%

Item 9 Labs Corp. Retains Sharp Capital Advisors to Facilitate a Sale of the Business

May 23, 2023

0.00%

Item 9 Labs Corp. Executes Major Restructuring to Pave the Way to Profitability

May 10, 2023

16.35%

Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls

April 13, 2023

6.67%

Unity Rd. To Exhibit at 2023 Multi-Unit Franchising Conference

April 6, 2023

16.67%

Item 9 Labs Corp. To Present at the Benzinga Spring Cannabis Capital Conference

conferences

March 29, 2023

3.64%

Item 9 Labs Corp. CEO Mike Weinberger Appointed To National Cannabis Industry Association’s Retail Committee

SEC Filings

View All

No SEC filings available for Item 9 Labs.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Item 9 Labs (INLB)?

The current stock price of Item 9 Labs (INLB) is $0.000001 as of April 9, 2025.

What is the market cap of Item 9 Labs (INLB)?

The market cap of Item 9 Labs (INLB) is approximately 10.2K.

What does Item 9 Labs Corp. specialize in?

Item 9 Labs Corp. specializes in the production of cannabis and cannabis-related products such as flower, concentrates, distillates, and hardware.

Where is the headquarters of Item 9 Labs Corp. located?

The headquarters of Item 9 Labs Corp. are located in Phoenix, Arizona.

What are some of the products offered by Item 9 Labs Corp.?

Item 9 Labs Corp. offers a variety of products including medical cannabis strains, shatter, crumble, badder, thca, delta 8 thc, broad spectrum distillate, and live resin terpene sauce.

Who has Item 9 Labs Corp. retained to assist in a potential sale of the Company?

Item 9 Labs Corp. has retained Sharp Capital Advisors LLC to assist in the exploration of a sale of the Company.

What are the two core operating businesses of Item 9 Labs Corp.?

The two core operating businesses of Item 9 Labs Corp. are Item 9 Labs and Unity Rd.

How does Item 9 Labs Corp. distribute its products?

Item 9 Labs Corp. distributes its products through licensed dispensaries to consumers in Arizona.

What additional asset does Item 9 Labs Corp. own?

Item 9 Labs Corp. owns an additional asset in Pahrump, Nevada consisting of a partially completed 20,000 ft2 facility on 4.6 acres of land.

When was Resolute Commercial Services appointed as the receiver for INLB?

Resolute Commercial Services was appointed as the receiver for INLB in July 2023 by the Superior Court of Arizona in the County of Maricopa.

What services does Sharp Capital Advisors LLC offer?

Sharp Capital Advisors LLC is a boutique investment banking firm delivering capital markets and M&A advisory services to the U.S. legal cannabis industry.

When was Resolute Commercial Services LLC founded?

Resolute Commercial Services LLC was founded in 2008 and offers financial advisory services focusing on resolving financial and operations issues impacting middle market companies.